Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent Ibrutinib.
Bone Marrow Transplant
; 57(5): 830-833, 2022 05.
Article
in En
| MEDLINE
| ID: mdl-35194155
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Red-Cell Aplasia, Pure
/
Hematopoietic Stem Cell Transplantation
Type of study:
Etiology_studies
Limits:
Humans
Language:
En
Journal:
Bone Marrow Transplant
Journal subject:
TRANSPLANTE
Year:
2022
Document type:
Article
Affiliation country:
United States